Literature DB >> 9066708

Apoptosis (programmed cell death) in idiopathic (primary) osteo-/myelofibrosis: naked nuclei in megakaryopoiesis reveal features of para-apoptosis.

J Thiele1, J Lorenzen, B Manich, H M Kvasnicka, T K Zirbes, R Fischer.   

Abstract

There is general agreement that apoptosis (programmed/physiological cell death) plays an important role in regulating normal hematopoiesis and that so-called naked nuclei (NN) present end stages of megakaryopoiesis. Using in situ end-labeling techniques (ISEL), a morphometric analysis was performed on bone marrow trephine biopsies repeatedly derived from patients with idiopathic (primary) osteo-/myelofibrosis (IMF). The purpose of this study was to quantify apoptosis and to elucidate its relationship with NN of megakaryopoiesis. Moreover, evolution of this phenomenon during progression of myelofibrosis (assessed by morphometry of silver-stained sequential biopsies) and its predictive value were investigated. In IMF, morphometric measurements revealed a rate of ISEL-positive cells that was significantly higher than previously published data on the normal bone marrow and in patients with acute myeloblastic leukemia, but lower than in the myelodysplastic syndromes. However, NN with their tightly packed (nuclear) lobules and condensed chromatin were not reactive. Statistical evaluation failed to show a significant correlation between incidence of apoptotic cells and fiber density or an increase in this feature associated with progression of fibro-osteosclerotic marrow changes and prognosis. The failure of NN to react in ISEL implicates an absence of DNA fragmentation characteristic of apoptosis. For this reason our findings are in keeping with the assumption that NN are compatible with para-apoptosis.

Entities:  

Mesh:

Year:  1997        PMID: 9066708     DOI: 10.1159/000203671

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  9 in total

Review 1.  GATA1 insufficiencies in primary myelofibrosis and other hematopoietic disorders: consequences for therapy.

Authors:  Te Ling; John D Crispino; Maria Zingariello; Fabrizio Martelli; Anna Rita Migliaccio
Journal:  Expert Rev Hematol       Date:  2018-02-19       Impact factor: 2.929

2.  Induction of platelet formation from megakaryocytoid cells by nitric oxide.

Authors:  E Battinelli; S R Willoughby; T Foxall; C R Valeri; J Loscalzo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-04       Impact factor: 11.205

3.  Activation of non-canonical TGF-β1 signaling indicates an autoimmune mechanism for bone marrow fibrosis in primary myelofibrosis.

Authors:  Fiorella Ciaffoni; Elena Cassella; Lilian Varricchio; Margherita Massa; Giovanni Barosi; Anna Rita Migliaccio
Journal:  Blood Cells Mol Dis       Date:  2015-01-15       Impact factor: 3.039

4.  Altered SDF-1/CXCR4 axis in patients with primary myelofibrosis and in the Gata1 low mouse model of the disease.

Authors:  Anna Rita Migliaccio; Fabrizio Martelli; Maria Verrucci; Giovanni Migliaccio; Alessandro Maria Vannucchi; Hongyu Ni; Mingjiang Xu; Yi Jiang; Betty Nakamoto; Thalia Papayannopoulou; Ronald Hoffman
Journal:  Exp Hematol       Date:  2008-02       Impact factor: 3.084

5.  A novel interaction between megakaryocytes and activated fibrocytes increases TGF-β bioavailability in the Gata1(low) mouse model of myelofibrosis.

Authors:  Maria Zingariello; Alessandra Ruggeri; Fabrizio Martelli; Manuela Marra; Laura Sancillo; Ilaria Ceglia; Rosa Alba Rana; Anna Rita Migliaccio
Journal:  Am J Blood Res       Date:  2015-12-25

Review 6.  Novel targets to cure primary myelofibrosis from studies on Gata1low mice.

Authors:  Maria Zingariello; Fabrizio Martelli; Paola Verachi; Claudio Bardelli; Francesca Gobbo; Maria Mazzarini; Anna Rita Migliaccio
Journal:  IUBMB Life       Date:  2019-11-21       Impact factor: 3.885

7.  Shared and Distinctive Ultrastructural Abnormalities Expressed by Megakaryocytes in Bone Marrow and Spleen From Patients With Myelofibrosis.

Authors:  Maria Zingariello; Vittorio Rosti; Alessandro M Vannucchi; Paola Guglielmelli; Maria Mazzarini; Giovanni Barosi; Maria Luisa Genova; Anna Rita Migliaccio
Journal:  Front Oncol       Date:  2020-11-16       Impact factor: 6.244

8.  Myelofibrosis: molecular and cell biological aspects.

Authors:  Hans Kreipe; Guntram Büsche; Oliver Bock; Kais Hussein
Journal:  Fibrogenesis Tissue Repair       Date:  2012-06-06

9.  Both Granulocytic and Non-Granulocytic Blood Cells Are Affected in Patients with Severe Congenital Neutropenia and Their Non-Neutropenic Family Members: An Evaluation of Morphology, Function, and Cell Death

Authors:  Lale Olcay; Şule Ünal; Hüseyin Onay; Esra Erdemli; Ayşenur Öztürk; Deniz Billur; Ayşe Metin; Hamza Okur; Yıldız Yıldırmak; Yahya Büyükaşık; Aydan İkincioğulları; Mesude Falay; Gülsüm Özet; Sevgi Yetgin
Journal:  Turk J Haematol       Date:  2018-07-24       Impact factor: 1.831

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.